Do low C3 and abnormal C4 levels reflect complement consumption and dysregulation?

Complement proteins C3 and C4 are central components of the innate immune response, serving as both participants in and biomarkers of the inflammatory process. In clinical practice, the measurement of these proteins provides a window into the systemic balance between immune activation and the body’s ability to clear inflammatory triggers.

Clinical evidence of consumption

Low serum levels of C3 and C4 are established markers for active immune complex-mediated diseases. In systemic lupus erythematosus (SLE), hypocomplementemia—specifically low C3 and C4—is a validated indicator of disease flares and organ involvement, such as lupus nephritis. International guidelines, including those from EULAR, utilize serial monitoring of these levels to assess treatment response and disease activity. Research involving patients with chronic active Epstein-Barr Virus (CAEBV) and ANCA-associated vasculitis also demonstrates that low complement levels correlate with active tissue deposition of immune fragments, confirming that serum depletion reflects active consumption at the site of inflammation.

Mechanistic basis of dysregulation

The reduction in C3 and C4 levels during chronic immune activation is driven by several precise molecular mechanisms:

• Immune Complex Formation: Chronic activation leads to the persistent generation of antigen-antibody aggregates (immune complexes).
• Classical Pathway Triggering: These complexes bind to C1q, initiating a proteolytic cascade that cleaves C4 and C3 into active fragments (C3a, C3b, C4a, C4b).
• Consumption Rate: In chronic states, the rate of cleavage and subsequent binding of these fragments to cell surfaces or complexes exceeds the liver's capacity for synthesis, resulting in measurable serum depletion.
• Amplification Loops: Cleavage products like C5a recruit neutrophils and promote NETosis, which releases further autoantigens, creating a self-perpetuating cycle of immune complex formation and complement consumption.

Practical considerations

While low levels typically indicate consumption, "abnormal" levels can also reflect genetic factors. For instance, C4 null alleles (genetic deficiencies) can impair the efficient clearance of immune complexes, thereby predisposing individuals to autoimmune conditions. Thus, abnormal C4 levels may represent both a consequence of consumption and a primary driver of immune dysregulation.

Bottom line

Low C3 and abnormal C4 levels are highly reliable indicators of complement consumption. This depletion occurs because chronic immune activation and immune complex activity trigger the complement cascade faster than the body can replenish these proteins.